Session

IBD (Posters)

SERUM PROTEOME PROFILES IN CROHN’S DISEASE PATIENTS WITH DIFFERENT PHENOTYPES TOWARDS BIOMARKER IDENTIFICATION
SERUM PROTEOME PROFILES IN CROHN’S DISEASE PATIENTS WITH DIFFERENT PHENOTYPES TOWARDS BIOMARKER IDENTIFICATION

MEASURING ADALIMUMAB AND INFLIXIMAB TROUGH LEVELS FROM FINGER PRICK BLOOD WITH A RAPID POINT-OF-CARE ASSAY
MEASURING ADALIMUMAB AND INFLIXIMAB TROUGH LEVELS FROM FINGER PRICK BLOOD WITH A RAPID POINT-OF-CARE ASSAY

USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY
USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY

COMPARISON OF CLINICAL IMPROVEMENT AS MEASURED BY TWO QUALITY-OF-LIFE INDEXES: A POOLED ANALYSIS OF VEDOLIZUMAB RANDOMIZED CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE
COMPARISON OF CLINICAL IMPROVEMENT AS MEASURED BY TWO QUALITY-OF-LIFE INDEXES: A POOLED ANALYSIS OF VEDOLIZUMAB RANDOMIZED CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE

THE BENEFICIAL EFFECTS OF INCREASING DIETARY FIBER CONSUMPTION ON CLINICAL FLARE AND INFLAMMATORY MARKERS AMONG PATIENTS WITH CLINICALLY QUIESCENT INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL STUDY
THE BENEFICIAL EFFECTS OF INCREASING DIETARY FIBER CONSUMPTION ON CLINICAL FLARE AND INFLAMMATORY MARKERS AMONG PATIENTS WITH CLINICALLY QUIESCENT INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL STUDY

IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS
IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS

CLAUDIN-2 OVEREXPRESSION IN STEM CELL ZONE CORRELATES WITH INCREASED INTESTINAL PERMEABILITY AND EPITHELIAL CELL PROLIFERATION DURING SHORT RECOVERY PERIOD IN ACUTE MURINE DSS MODEL OF INFLAMMATORY BOWEL DISEASE
CLAUDIN-2 OVEREXPRESSION IN STEM CELL ZONE CORRELATES WITH INCREASED INTESTINAL PERMEABILITY AND EPITHELIAL CELL PROLIFERATION DURING SHORT RECOVERY PERIOD IN ACUTE MURINE DSS MODEL OF INFLAMMATORY BOWEL DISEASE

PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?
PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?

INVESTIGATION OF SOMATIC MUTATIONS IN BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
INVESTIGATION OF SOMATIC MUTATIONS IN BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE

OPIOID EXPOSURE IN IBD AND ASSOCIATED FACTORS: A UK PROSPECTIVE MULTICENTRE AUDIT OF 1362 PATIENTS
OPIOID EXPOSURE IN IBD AND ASSOCIATED FACTORS: A UK PROSPECTIVE MULTICENTRE AUDIT OF 1362 PATIENTS

EFFECTIVENESS OF POLYMERIC EXCLUSIVE ENTERAL NUTRITION AS AN ADJUNCT TO STANDARD OF CARE IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
EFFECTIVENESS OF POLYMERIC EXCLUSIVE ENTERAL NUTRITION AS AN ADJUNCT TO STANDARD OF CARE IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

DEEP LEARNING-BASED IMAGE ANALYSIS REVEALS SIGNIFICANT DIFFERENCES IN NUMBER AND DISTRIBUTION OF CD3 AND GAMMA-DELTA T CELLS BETWEEN CROHN’S COLITIS AND ULCERATIVE COLITIS
DEEP LEARNING-BASED IMAGE ANALYSIS REVEALS SIGNIFICANT DIFFERENCES IN NUMBER AND DISTRIBUTION OF CD3 AND GAMMA-DELTA T CELLS BETWEEN CROHN’S COLITIS AND ULCERATIVE COLITIS

LATENT CROHN’S DISEASE SUBGROUPS ARE IDENTIFIED BY FAECAL CALPROTECTIN PROFILES: A RETROSPECTIVE ANALYSIS OF THE LOTHIAN CROHN’S DISEASE INCEPTION COHORT
LATENT CROHN’S DISEASE SUBGROUPS ARE IDENTIFIED BY FAECAL CALPROTECTIN PROFILES: A RETROSPECTIVE ANALYSIS OF THE LOTHIAN CROHN’S DISEASE INCEPTION COHORT

USE OF HAEMATOLOGICAL IRON PARAMETERS ALONE OR IN COMBINATION TO DETECT IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE
USE OF HAEMATOLOGICAL IRON PARAMETERS ALONE OR IN COMBINATION TO DETECT IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE

INTERACTION BETWEEN CHITINASE 3-LIKE 1 (CHI3L1) AND BACTERIAL PROTEIN CHIA: A DECISIVE STEP FOR CROHN’S DISEASE-ASSOCIATED ADHERENT AND INVASIVE E. COLI TO ENTER WITHIN HUMAN MACROPHAGES
INTERACTION BETWEEN CHITINASE 3-LIKE 1 (CHI3L1) AND BACTERIAL PROTEIN CHIA: A DECISIVE STEP FOR CROHN’S DISEASE-ASSOCIATED ADHERENT AND INVASIVE E. COLI TO ENTER WITHIN HUMAN MACROPHAGES

ASSESSMENT OF HISTOLOGICAL REMISSION IN PATIENTS TREATED WITH FILGOTINIB BY DIFFERENT SCORES AND CONCORDANCE WITH ENDOSCOPIC AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES: POST HOC ANALYSIS FROM THE SELECTION STUDY
ASSESSMENT OF HISTOLOGICAL REMISSION IN PATIENTS TREATED WITH FILGOTINIB BY DIFFERENT SCORES AND CONCORDANCE WITH ENDOSCOPIC AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES: POST HOC ANALYSIS FROM THE SELECTION STUDY

TRANSCRIPTOME CHANGES IN A COMMENSAL ESCHERICHIA COLI STRAIN FROM HEALTHY DONOR AFTER INCUBATION WITH IGA IN VITRO
TRANSCRIPTOME CHANGES IN A COMMENSAL ESCHERICHIA COLI STRAIN FROM HEALTHY DONOR AFTER INCUBATION WITH IGA IN VITRO

CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

POTENTIAL BIOMARKER PAI-1 PROMOTES THE DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN BIOLOGICAL SAMPLES OF INFLAMMATORY BOWEL DISEASES
POTENTIAL BIOMARKER PAI-1 PROMOTES THE DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN BIOLOGICAL SAMPLES OF INFLAMMATORY BOWEL DISEASES

THE IMPACT OF VITAMIN D DEFICIENCY ON COVID-19 INFECTION AND RESPONSE TO VACCINATION
THE IMPACT OF VITAMIN D DEFICIENCY ON COVID-19 INFECTION AND RESPONSE TO VACCINATION

Item 61 - 80 / 612
1 2 3
4
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31